Optimizing adjuvant treatment strategies for non-pancreatic periampullary cancers.

Nouredin MessaoudiAude VanlanderAndrew A Gumbs

Published in: British journal of cancer (2024)

Non-pancreatic periampullary tumors have long been neglected, leading to blurred adjuvant treatment strategies. Recent research, like the ISGACA group's study, is uncovering nuances in chemotherapy efficacy for these diverse cancers. Tailored approaches show promise, with artificial intelligence (AI) aiding in personalized treatment plans.

Keyphrases

artificial intelligence
big data
machine learning
deep learning
early stage
smoking cessation
health insurance
combination therapy
chemotherapy induced
replacement therapy